PTC Therapeutics Inc PTC518 Phase 1 Huntington's Disease Program Update Conference Call Transcript
Good day, and thank you for standing by. Welcome to the PTC518 Data Release Conference Call. (Operator Instructions) After the speakers' presentation there'll be a question-and-answer session. (Operator Instructions) Please be advised that today's conference may be recorded.
I would now like to hand the conference over to your speaker today, Kylie O'Keefe, Senior Vice President of Global, Commercial and Corporate Strategy. Please go ahead.
' -
Good morning, everyone, and thank you for joining us. Today we'll be discussing the results of our PTC518 program in Huntington's disease. Joining me on today's call is our Chief Executive Officer, Dr. Stuart Peltz; and our Chief Development Officer, Dr. Matthew Klein. As a reminder, slides are available in the Investors section of the website for you to follow along during the presentation today.
I will now pass the call over to our Chief Executive Officer, Stuart Peltz. Stuart?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |